Welcome
Welcome to The Informer, the monthly essential newsletter for ODS-Cs and aspiring Cancer Registry professionals. Packed with specially curated educational opportunities, industry updates, and practical resources, our goal is to keep you informed and equipped to excel in this vital field. Don’t miss an edition-scroll to the bottom of this page to sign up to receive The Informer directly to your inbox.
Education
Register by Sept. 11! District of Columbia Cancer Registry Education Conference (Hybrid)
The District of Columbia Cancer Registry will be hosting the 10th Annual Education Conference on September 25, from 9:00 a.m. to 3:30 p.m. at the Department of Health of the District of Columbia. This year's theme is: "Unmasking Pancreatic Cancer: From Early Detection to Better Outcomes."
Keynote speaker Frederick L. Greene, MD, FACS, will present "Recent Advances in the Management of Pancreatic Cancer: 2026 and Beyond." DCCR Epidemiologist Sharmila Chatterjee, MBBS, MPH, CPH, will also share an epi moment on pancreatic cancer incidence and mortality trends in the District of Columbia.
If interested in attending in person or virtually, please complete the registration form by Friday, September 11. Registration is free and CE hours will be awarded for virtual attendees. https://forms.cloud.microsoft/g/GRnYU2BAZz
Final 2026 FCDS educational series webinar for Florida IDEA users
The last FCDS educational webinar for 2026, CNS, Part II, will be webcast October 14.
The webinars are free, recorded with the CEU quiz available on the FLccSC website for IDEA users.
HEME, Part I (on demand)
NCRA CEU#: 2026-039, 2 CEUs Awarded, meets Category A
Please take FLccSC quiz to get the CEUs
HEME, Part II (on demand)
NCRA CEU#: 2026-041, 2 CEUs Awarded, meets Category A
Please take FLccSC quiz to get the CEUs
Recording, Handouts, Quizzes/Answers
CNS, Part I (on demand)
NCRA CEU#: 2026-041, 2 CEUs Awarded, meets Category A
Please take FLccSC quiz to get the CEUs
Recording, Handouts, Quizzes/Answers
CNS, Part II (live webinar)
October 14, 2026 from 10am-12pm ET
NCRA CEU#: 2026-042, 2 CEUs Awarded, meets Category A
Recording now available: 2026 Mid-Year Update (SSDIs and Solid Tumor Rules 2026.1)
The recording, slides and Q&A from NAACCR’s August 24th webinar, 2026 Mid-Year Update (SSDIs and Solid Tumor Rules 2026.1), are now available.
The webinar provides a high-level review of 2026 changes, issues related to SSDIs and discussion of the Solid Tumor Rules 2026.1.
CEs are not available for this educational activity.
Resources, job aids and technology tips
Updated NAACCR v27 annotated histology list
On August 21, NAACCR released an updated v27 annotated histology list. The update provided corrected histology for 9750/3, 9805/3, 9835/3, 9971/1, 9971/3, and 9987/3. The updated list is available on NAACCRs ICD-O-3 webpage.
NAACCR 2027 Implementation Guidelines posted
The NAACCR Implementation Guidelines (IG) for 2027 are available on the NAACCR implementation and guidelines page. The IG provide standard setters, registries and software vendors with a comprehensive review of the changes planned for 2027. These changes include new data items, revisions to existing data items, updates to standard setter requirements, and more.
Detailed specifications for conversion from v26 to v27 will be posted in a separate Excel spreadsheet in September.
QA knowledge challenge
Casefinding
Patient had an MRI of the neck that showed a 2.7 cm enhancing mass centered within the right carotid space at the level of the carotid bifurcation, suggestive of a peripheral nerve sheath tumor (schwannoma). Surgical resection of the carotid space tumor was done, and pathology confirmed a WHO Gr 1 schwannoma. Is this case reportable?
- Yes
- No
Your next step in cancer registry
Savista is committed to supporting your growth in the Cancer Registry field. Whether you’re looking to expand your skills or take the next step in your career, we’re here to help. Explore our open registry positions and join a team dedicated to advancing cancer data excellence.
QA knowledge challenge answer
B. No.
The location of this tumor was in the carotid space in the neck. It was not a CNS tumor.
Schwannomas are derived from Schwann cells which are glial cells that are a part of the peripheral nervous system, not the central nervous system. Schwannomas are benign tumors but are only reportable if intradural (within the dura). The dura is the lining of the brain and spinal cord, so only schwannoma’s that involve intracranial nerves or spinal nerve roots are reportable.
Subscribe to The Informer newsletter to receive new editions right to your inbox
